René Fáber

Sartorius Stedim Fmt SAS manufactures plastic packaging products. It serves to biopharmaceutical, chemical, food, and academic labs. The firm's product portfolio includes cell analysis, bioreactors, lab filtration, fluid management, and water purification. The company is headquartered in Aubagne, France.

Part of Sartorius AG, Albumedix Ltd. is a British science-driven company and recognized leader of albumin-enabled solutions. The company, based in Nottingham, UK, was founded in 1984 with a mission to empower excellence. Albumedix has supported its life-science partners in delivering safe doses of clinical and marketed therapeutics. The company's solutions include the world's only USP-NF compliant recombinant human albumin, client-centric development and compliance services, and drug-enhancing technologies. By challenging the status quo and striving for more, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals. Albumedix is the world leader in recombinant human albumin and has developed a portfolio of products known as Recombumin®. Founded in 1973, the CEO of Albumedix is Jonas S. Moller. The company was acquired by Sartorius Stedim Biotech SA on September 30, 2022, for $500.47 million.

Part of Sartorius AG, Sartorius Stedim North America Holding GmbH provides financial services. The company is based in Goettingen, Germany. The CEO of the German company is Uwe Becker.

Part of Sartorius AG, Sartorius Xell GmbH is a German company that specializes in providing solutions tailored to the specific requirements of cell lines, allowing them to achieve optimal product yields. The company, founded in 2009, is based in Schloß Holte-Stukenbrock, Germany. Xell's expertise lies in developing customized production processes, including cell culture media, feeds, and medical products. The company's team of highly skilled and motivated employees, with diverse scientific backgrounds, emphasizes a strong focus on technology and innovation. Sartorius Xell was acquired by Sartorius Stedim Biotech SA on July 29, 2021.